nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—CDK14—brain—intracranial aneurysm	0.00147	0.00306	CbGeAlD
Sunitinib—MAP3K12—medulla oblongata—intracranial aneurysm	0.00146	0.00304	CbGeAlD
Sunitinib—NUAK1—cerebellum—intracranial aneurysm	0.00146	0.00304	CbGeAlD
Sunitinib—CDK16—brain—intracranial aneurysm	0.00145	0.00302	CbGeAlD
Sunitinib—LATS2—brain—intracranial aneurysm	0.00145	0.00302	CbGeAlD
Sunitinib—PAK3—brain—intracranial aneurysm	0.00145	0.00302	CbGeAlD
Sunitinib—OXSR1—cerebellum—intracranial aneurysm	0.00145	0.00301	CbGeAlD
Sunitinib—SNRK—cerebellum—intracranial aneurysm	0.00145	0.00301	CbGeAlD
Sunitinib—INSR—cerebellum—intracranial aneurysm	0.00145	0.00301	CbGeAlD
Sunitinib—RPS6KA3—medulla oblongata—intracranial aneurysm	0.00144	0.003	CbGeAlD
Sunitinib—STK33—brain—intracranial aneurysm	0.00143	0.00298	CbGeAlD
Sunitinib—RPS6KA5—brain—intracranial aneurysm	0.00143	0.00298	CbGeAlD
Sunitinib—STK38—cerebellum—intracranial aneurysm	0.00143	0.00296	CbGeAlD
Sunitinib—RPS6KA2—cerebellum—intracranial aneurysm	0.00143	0.00296	CbGeAlD
Sunitinib—CSNK1A1—medulla oblongata—intracranial aneurysm	0.00141	0.00294	CbGeAlD
Sunitinib—CLK1—medulla oblongata—intracranial aneurysm	0.0014	0.00292	CbGeAlD
Sunitinib—CSNK1G2—cerebellum—intracranial aneurysm	0.0014	0.00292	CbGeAlD
Sunitinib—PKN1—cerebellum—intracranial aneurysm	0.0014	0.00292	CbGeAlD
Sunitinib—TAOK3—brainstem—intracranial aneurysm	0.0014	0.0029	CbGeAlD
Sunitinib—PRPF4—cerebellum—intracranial aneurysm	0.00138	0.00288	CbGeAlD
Sunitinib—CAMK2G—medulla oblongata—intracranial aneurysm	0.00138	0.00287	CbGeAlD
Sunitinib—CLK4—brain—intracranial aneurysm	0.00138	0.00287	CbGeAlD
Sunitinib—LRRK2—medulla oblongata—intracranial aneurysm	0.00137	0.00284	CbGeAlD
Sunitinib—PRPF4B—cerebellum—intracranial aneurysm	0.00136	0.00284	CbGeAlD
Sunitinib—SBK1—brain—intracranial aneurysm	0.00136	0.00283	CbGeAlD
Sunitinib—MAP4K4—midbrain—intracranial aneurysm	0.00136	0.00282	CbGeAlD
Sunitinib—HIPK4—brain—intracranial aneurysm	0.00135	0.0028	CbGeAlD
Sunitinib—STK39—cerebellum—intracranial aneurysm	0.00135	0.0028	CbGeAlD
Sunitinib—MAP3K12—midbrain—intracranial aneurysm	0.00134	0.00278	CbGeAlD
Sunitinib—PHKG1—brain—intracranial aneurysm	0.00133	0.00277	CbGeAlD
Sunitinib—DAPK1—brain—intracranial aneurysm	0.00133	0.00277	CbGeAlD
Sunitinib—CSNK2A1—cerebellum—intracranial aneurysm	0.00133	0.00276	CbGeAlD
Sunitinib—RPS6KA3—midbrain—intracranial aneurysm	0.00132	0.00274	CbGeAlD
Sunitinib—MYLK—cerebellum—intracranial aneurysm	0.00131	0.00272	CbGeAlD
Sunitinib—CSNK1E—medulla oblongata—intracranial aneurysm	0.00131	0.00272	CbGeAlD
Sunitinib—FGFR1—medulla oblongata—intracranial aneurysm	0.00131	0.00272	CbGeAlD
Sunitinib—CSNK1A1—midbrain—intracranial aneurysm	0.00129	0.00269	CbGeAlD
Sunitinib—IRAK4—medulla oblongata—intracranial aneurysm	0.00129	0.00268	CbGeAlD
Sunitinib—STK11—brain—intracranial aneurysm	0.00129	0.00268	CbGeAlD
Sunitinib—BRD4—brain—intracranial aneurysm	0.00129	0.00268	CbGeAlD
Sunitinib—STK4—cerebellum—intracranial aneurysm	0.00129	0.00267	CbGeAlD
Sunitinib—CLK1—midbrain—intracranial aneurysm	0.00128	0.00267	CbGeAlD
Sunitinib—RPS6KA1—brain—intracranial aneurysm	0.00128	0.00265	CbGeAlD
Sunitinib—RIOK1—brain—intracranial aneurysm	0.00128	0.00265	CbGeAlD
Sunitinib—PHKG2—cerebellum—intracranial aneurysm	0.00126	0.00263	CbGeAlD
Sunitinib—MAP2K2—medulla oblongata—intracranial aneurysm	0.00126	0.00262	CbGeAlD
Sunitinib—ULK3—medulla oblongata—intracranial aneurysm	0.00126	0.00262	CbGeAlD
Sunitinib—CAMK2G—midbrain—intracranial aneurysm	0.00126	0.00262	CbGeAlD
Sunitinib—BMP2K—midbrain—intracranial aneurysm	0.00126	0.00262	CbGeAlD
Sunitinib—STK24—cerebellum—intracranial aneurysm	0.00126	0.00261	CbGeAlD
Sunitinib—MARK2—brain—intracranial aneurysm	0.00125	0.0026	CbGeAlD
Sunitinib—TNIK—brain—intracranial aneurysm	0.00125	0.0026	CbGeAlD
Sunitinib—MAP2K5—brainstem—intracranial aneurysm	0.00125	0.0026	CbGeAlD
Sunitinib—LRRK2—midbrain—intracranial aneurysm	0.00125	0.0026	CbGeAlD
Sunitinib—DAPK2—cerebellum—intracranial aneurysm	0.00124	0.00258	CbGeAlD
Sunitinib—MAP3K7—medulla oblongata—intracranial aneurysm	0.00124	0.00258	CbGeAlD
Sunitinib—SGK3—brain—intracranial aneurysm	0.00124	0.00258	CbGeAlD
Sunitinib—ICK—brain—intracranial aneurysm	0.00123	0.00255	CbGeAlD
Sunitinib—TBK1—medulla oblongata—intracranial aneurysm	0.00123	0.00255	CbGeAlD
Sunitinib—STK16—cerebellum—intracranial aneurysm	0.00122	0.00254	CbGeAlD
Sunitinib—TYK2—medulla oblongata—intracranial aneurysm	0.00122	0.00253	CbGeAlD
Sunitinib—HIPK3—cerebellum—intracranial aneurysm	0.00122	0.00253	CbGeAlD
Sunitinib—HIPK2—cerebellum—intracranial aneurysm	0.00122	0.00253	CbGeAlD
Sunitinib—TYRO3—cerebellum—intracranial aneurysm	0.00122	0.00253	CbGeAlD
Sunitinib—TNK1—cerebellum—intracranial aneurysm	0.0012	0.0025	CbGeAlD
Sunitinib—RIOK2—cerebellum—intracranial aneurysm	0.0012	0.0025	CbGeAlD
Sunitinib—CSNK1E—midbrain—intracranial aneurysm	0.0012	0.00249	CbGeAlD
Sunitinib—FGFR1—midbrain—intracranial aneurysm	0.0012	0.00249	CbGeAlD
Sunitinib—CHEK2—brain—intracranial aneurysm	0.00119	0.00247	CbGeAlD
Sunitinib—NUAK1—brain—intracranial aneurysm	0.00119	0.00247	CbGeAlD
Sunitinib—RPS6KB1—medulla oblongata—intracranial aneurysm	0.00118	0.00245	CbGeAlD
Sunitinib—OXSR1—brain—intracranial aneurysm	0.00118	0.00245	CbGeAlD
Sunitinib—INSR—brain—intracranial aneurysm	0.00118	0.00245	CbGeAlD
Sunitinib—SNRK—brain—intracranial aneurysm	0.00118	0.00245	CbGeAlD
Sunitinib—RET—medulla oblongata—intracranial aneurysm	0.00117	0.00244	CbGeAlD
Sunitinib—DAPK3—cerebellum—intracranial aneurysm	0.00117	0.00243	CbGeAlD
Sunitinib—AXL—medulla oblongata—intracranial aneurysm	0.00117	0.00243	CbGeAlD
Sunitinib—STK38—brain—intracranial aneurysm	0.00116	0.00241	CbGeAlD
Sunitinib—RPS6KA2—brain—intracranial aneurysm	0.00116	0.00241	CbGeAlD
Sunitinib—CLK2—cerebellum—intracranial aneurysm	0.00116	0.00241	CbGeAlD
Sunitinib—MAP2K2—midbrain—intracranial aneurysm	0.00115	0.0024	CbGeAlD
Sunitinib—ULK3—midbrain—intracranial aneurysm	0.00115	0.0024	CbGeAlD
Sunitinib—MAP4K2—cerebellum—intracranial aneurysm	0.00115	0.00239	CbGeAlD
Sunitinib—AURKC—brain—intracranial aneurysm	0.00115	0.00239	CbGeAlD
Sunitinib—CSNK1G2—brain—intracranial aneurysm	0.00114	0.00237	CbGeAlD
Sunitinib—PKN1—brain—intracranial aneurysm	0.00114	0.00237	CbGeAlD
Sunitinib—STK3—cerebellum—intracranial aneurysm	0.00114	0.00236	CbGeAlD
Sunitinib—MAP3K7—midbrain—intracranial aneurysm	0.00113	0.00236	CbGeAlD
Sunitinib—SLK—medulla oblongata—intracranial aneurysm	0.00112	0.00234	CbGeAlD
Sunitinib—PRPF4—brain—intracranial aneurysm	0.00112	0.00234	CbGeAlD
Sunitinib—TBK1—midbrain—intracranial aneurysm	0.00112	0.00233	CbGeAlD
Sunitinib—TYK2—midbrain—intracranial aneurysm	0.00111	0.00231	CbGeAlD
Sunitinib—KIT—brainstem—intracranial aneurysm	0.00111	0.00231	CbGeAlD
Sunitinib—JAK2—medulla oblongata—intracranial aneurysm	0.00111	0.0023	CbGeAlD
Sunitinib—PRPF4B—brain—intracranial aneurysm	0.00111	0.0023	CbGeAlD
Sunitinib—IRAK1—midbrain—intracranial aneurysm	0.0011	0.00228	CbGeAlD
Sunitinib—DYRK1A—cerebellum—intracranial aneurysm	0.00109	0.00227	CbGeAlD
Sunitinib—FYN—medulla oblongata—intracranial aneurysm	0.00109	0.00227	CbGeAlD
Sunitinib—STK39—brain—intracranial aneurysm	0.00109	0.00227	CbGeAlD
Sunitinib—CSNK2A1—brain—intracranial aneurysm	0.00108	0.00224	CbGeAlD
Sunitinib—RPS6KB1—midbrain—intracranial aneurysm	0.00108	0.00224	CbGeAlD
Sunitinib—RET—midbrain—intracranial aneurysm	0.00107	0.00223	CbGeAlD
Sunitinib—MERTK—cerebellum—intracranial aneurysm	0.00107	0.00222	CbGeAlD
Sunitinib—MAP4K5—medulla oblongata—intracranial aneurysm	0.00107	0.00222	CbGeAlD
Sunitinib—MAP3K3—medulla oblongata—intracranial aneurysm	0.00107	0.00222	CbGeAlD
Sunitinib—AXL—midbrain—intracranial aneurysm	0.00107	0.00222	CbGeAlD
Sunitinib—MYLK—brain—intracranial aneurysm	0.00106	0.00221	CbGeAlD
Sunitinib—PLK4—brain—intracranial aneurysm	0.00105	0.00219	CbGeAlD
Sunitinib—MAP4K4—cerebellum—intracranial aneurysm	0.00105	0.00218	CbGeAlD
Sunitinib—STK4—brain—intracranial aneurysm	0.00104	0.00217	CbGeAlD
Sunitinib—NUAK2—cerebellum—intracranial aneurysm	0.00104	0.00216	CbGeAlD
Sunitinib—MAP3K12—cerebellum—intracranial aneurysm	0.00103	0.00215	CbGeAlD
Sunitinib—FLT3—cerebellum—intracranial aneurysm	0.00103	0.00215	CbGeAlD
Sunitinib—FLT1—medulla oblongata—intracranial aneurysm	0.00103	0.00215	CbGeAlD
Sunitinib—SLK—midbrain—intracranial aneurysm	0.00103	0.00214	CbGeAlD
Sunitinib—PHKG2—brain—intracranial aneurysm	0.00103	0.00213	CbGeAlD
Sunitinib—EPHB6—medulla oblongata—intracranial aneurysm	0.00102	0.00212	CbGeAlD
Sunitinib—STK24—brain—intracranial aneurysm	0.00102	0.00212	CbGeAlD
Sunitinib—RPS6KA3—cerebellum—intracranial aneurysm	0.00102	0.00212	CbGeAlD
Sunitinib—MAP2K1—cerebellum—intracranial aneurysm	0.00101	0.00211	CbGeAlD
Sunitinib—DAPK2—brain—intracranial aneurysm	0.00101	0.0021	CbGeAlD
Sunitinib—CSNK1A1—cerebellum—intracranial aneurysm	0.000999	0.00208	CbGeAlD
Sunitinib—FYN—midbrain—intracranial aneurysm	0.000999	0.00208	CbGeAlD
Sunitinib—CLK1—cerebellum—intracranial aneurysm	0.000993	0.00206	CbGeAlD
Sunitinib—STK16—brain—intracranial aneurysm	0.000993	0.00206	CbGeAlD
Sunitinib—HIPK2—brain—intracranial aneurysm	0.000987	0.00205	CbGeAlD
Sunitinib—HIPK3—brain—intracranial aneurysm	0.000987	0.00205	CbGeAlD
Sunitinib—ALK—brain—intracranial aneurysm	0.000987	0.00205	CbGeAlD
Sunitinib—TYRO3—brain—intracranial aneurysm	0.000987	0.00205	CbGeAlD
Sunitinib—YES1—medulla oblongata—intracranial aneurysm	0.000986	0.00205	CbGeAlD
Sunitinib—TNK1—brain—intracranial aneurysm	0.000977	0.00203	CbGeAlD
Sunitinib—RIOK2—brain—intracranial aneurysm	0.000977	0.00203	CbGeAlD
Sunitinib—MAP4K5—midbrain—intracranial aneurysm	0.000976	0.00203	CbGeAlD
Sunitinib—MAP3K3—midbrain—intracranial aneurysm	0.000976	0.00203	CbGeAlD
Sunitinib—BMP2K—cerebellum—intracranial aneurysm	0.000975	0.00203	CbGeAlD
Sunitinib—CAMK2G—cerebellum—intracranial aneurysm	0.000975	0.00203	CbGeAlD
Sunitinib—TAOK3—medulla oblongata—intracranial aneurysm	0.000973	0.00202	CbGeAlD
Sunitinib—MAP3K19—brain—intracranial aneurysm	0.000967	0.00201	CbGeAlD
Sunitinib—MAP4K1—brain—intracranial aneurysm	0.000967	0.00201	CbGeAlD
Sunitinib—LRRK2—cerebellum—intracranial aneurysm	0.000966	0.00201	CbGeAlD
Sunitinib—PRKAA1—cerebellum—intracranial aneurysm	0.000952	0.00198	CbGeAlD
Sunitinib—DAPK3—brain—intracranial aneurysm	0.000949	0.00197	CbGeAlD
Sunitinib—FLT1—midbrain—intracranial aneurysm	0.000944	0.00196	CbGeAlD
Sunitinib—PTK2B—cerebellum—intracranial aneurysm	0.000941	0.00196	CbGeAlD
Sunitinib—CLK2—brain—intracranial aneurysm	0.00094	0.00195	CbGeAlD
Sunitinib—MAP4K2—brain—intracranial aneurysm	0.000935	0.00195	CbGeAlD
Sunitinib—EPHB6—midbrain—intracranial aneurysm	0.000933	0.00194	CbGeAlD
Sunitinib—CSNK1E—cerebellum—intracranial aneurysm	0.000926	0.00193	CbGeAlD
Sunitinib—FGFR1—cerebellum—intracranial aneurysm	0.000926	0.00193	CbGeAlD
Sunitinib—STK3—brain—intracranial aneurysm	0.000923	0.00192	CbGeAlD
Sunitinib—IRAK4—cerebellum—intracranial aneurysm	0.000912	0.0019	CbGeAlD
Sunitinib—ROCK1—brain—intracranial aneurysm	0.000911	0.00189	CbGeAlD
Sunitinib—YES1—midbrain—intracranial aneurysm	0.000901	0.00187	CbGeAlD
Sunitinib—ULK3—cerebellum—intracranial aneurysm	0.000891	0.00185	CbGeAlD
Sunitinib—MAP2K2—cerebellum—intracranial aneurysm	0.000891	0.00185	CbGeAlD
Sunitinib—TAOK3—midbrain—intracranial aneurysm	0.00089	0.00185	CbGeAlD
Sunitinib—DYRK1A—brain—intracranial aneurysm	0.000888	0.00185	CbGeAlD
Sunitinib—MAP3K2—cerebellum—intracranial aneurysm	0.000885	0.00184	CbGeAlD
Sunitinib—MAP3K7—cerebellum—intracranial aneurysm	0.000877	0.00182	CbGeAlD
Sunitinib—KDR—medulla oblongata—intracranial aneurysm	0.000873	0.00181	CbGeAlD
Sunitinib—MAP2K5—medulla oblongata—intracranial aneurysm	0.000873	0.00181	CbGeAlD
Sunitinib—MERTK—brain—intracranial aneurysm	0.000868	0.0018	CbGeAlD
Sunitinib—TBK1—cerebellum—intracranial aneurysm	0.000867	0.0018	CbGeAlD
Sunitinib—TYK2—cerebellum—intracranial aneurysm	0.000861	0.00179	CbGeAlD
Sunitinib—CSF1R—medulla oblongata—intracranial aneurysm	0.000852	0.00177	CbGeAlD
Sunitinib—MAP4K4—brain—intracranial aneurysm	0.000852	0.00177	CbGeAlD
Sunitinib—IRAK1—cerebellum—intracranial aneurysm	0.00085	0.00177	CbGeAlD
Sunitinib—NUAK2—brain—intracranial aneurysm	0.000846	0.00176	CbGeAlD
Sunitinib—MAP3K12—brain—intracranial aneurysm	0.00084	0.00175	CbGeAlD
Sunitinib—RPS6KB1—cerebellum—intracranial aneurysm	0.000834	0.00173	CbGeAlD
Sunitinib—RET—cerebellum—intracranial aneurysm	0.000829	0.00172	CbGeAlD
Sunitinib—RPS6KA3—brain—intracranial aneurysm	0.000828	0.00172	CbGeAlD
Sunitinib—AXL—cerebellum—intracranial aneurysm	0.000825	0.00172	CbGeAlD
Sunitinib—MAP2K1—brain—intracranial aneurysm	0.000822	0.00171	CbGeAlD
Sunitinib—CSNK1A1—brain—intracranial aneurysm	0.000812	0.00169	CbGeAlD
Sunitinib—CLK1—brain—intracranial aneurysm	0.000807	0.00168	CbGeAlD
Sunitinib—KDR—midbrain—intracranial aneurysm	0.000798	0.00166	CbGeAlD
Sunitinib—MAP2K5—midbrain—intracranial aneurysm	0.000798	0.00166	CbGeAlD
Sunitinib—SLK—cerebellum—intracranial aneurysm	0.000795	0.00165	CbGeAlD
Sunitinib—CAMK2G—brain—intracranial aneurysm	0.000792	0.00165	CbGeAlD
Sunitinib—BMP2K—brain—intracranial aneurysm	0.000792	0.00165	CbGeAlD
Sunitinib—FGFR2—cerebellum—intracranial aneurysm	0.000787	0.00164	CbGeAlD
Sunitinib—LRRK2—brain—intracranial aneurysm	0.000785	0.00163	CbGeAlD
Sunitinib—JAK2—cerebellum—intracranial aneurysm	0.000783	0.00163	CbGeAlD
Sunitinib—CSF1R—midbrain—intracranial aneurysm	0.000778	0.00162	CbGeAlD
Sunitinib—KIT—medulla oblongata—intracranial aneurysm	0.000773	0.00161	CbGeAlD
Sunitinib—PRKAA1—brain—intracranial aneurysm	0.000773	0.00161	CbGeAlD
Sunitinib—FYN—cerebellum—intracranial aneurysm	0.000773	0.00161	CbGeAlD
Sunitinib—PTK2B—brain—intracranial aneurysm	0.000765	0.00159	CbGeAlD
Sunitinib—FLT4—brain—intracranial aneurysm	0.000763	0.00159	CbGeAlD
Sunitinib—PDGFRB—medulla oblongata—intracranial aneurysm	0.000755	0.00157	CbGeAlD
Sunitinib—MAP4K5—cerebellum—intracranial aneurysm	0.000755	0.00157	CbGeAlD
Sunitinib—MAP3K3—cerebellum—intracranial aneurysm	0.000755	0.00157	CbGeAlD
Sunitinib—FGFR1—brain—intracranial aneurysm	0.000752	0.00156	CbGeAlD
Sunitinib—CSNK1E—brain—intracranial aneurysm	0.000752	0.00156	CbGeAlD
Sunitinib—IRAK4—brain—intracranial aneurysm	0.000741	0.00154	CbGeAlD
Sunitinib—FLT1—cerebellum—intracranial aneurysm	0.00073	0.00152	CbGeAlD
Sunitinib—MAP2K2—brain—intracranial aneurysm	0.000724	0.00151	CbGeAlD
Sunitinib—ULK3—brain—intracranial aneurysm	0.000724	0.00151	CbGeAlD
Sunitinib—EPHB6—cerebellum—intracranial aneurysm	0.000722	0.0015	CbGeAlD
Sunitinib—MAP3K2—brain—intracranial aneurysm	0.000719	0.00149	CbGeAlD
Sunitinib—MAP3K7—brain—intracranial aneurysm	0.000712	0.00148	CbGeAlD
Sunitinib—KIT—midbrain—intracranial aneurysm	0.000707	0.00147	CbGeAlD
Sunitinib—TBK1—brain—intracranial aneurysm	0.000704	0.00146	CbGeAlD
Sunitinib—TYK2—brain—intracranial aneurysm	0.000699	0.00145	CbGeAlD
Sunitinib—YES1—cerebellum—intracranial aneurysm	0.000697	0.00145	CbGeAlD
Sunitinib—STK10—cerebellum—intracranial aneurysm	0.000691	0.00144	CbGeAlD
Sunitinib—PDGFRB—midbrain—intracranial aneurysm	0.00069	0.00144	CbGeAlD
Sunitinib—IRAK1—brain—intracranial aneurysm	0.00069	0.00144	CbGeAlD
Sunitinib—TAOK3—cerebellum—intracranial aneurysm	0.000688	0.00143	CbGeAlD
Sunitinib—PDGFRA—cerebellum—intracranial aneurysm	0.000684	0.00142	CbGeAlD
Sunitinib—RPS6KB1—brain—intracranial aneurysm	0.000677	0.00141	CbGeAlD
Sunitinib—RET—brain—intracranial aneurysm	0.000673	0.0014	CbGeAlD
Sunitinib—FGR—brain—intracranial aneurysm	0.000673	0.0014	CbGeAlD
Sunitinib—AXL—brain—intracranial aneurysm	0.00067	0.00139	CbGeAlD
Sunitinib—SLK—brain—intracranial aneurysm	0.000645	0.00134	CbGeAlD
Sunitinib—FGFR2—brain—intracranial aneurysm	0.00064	0.00133	CbGeAlD
Sunitinib—JAK2—brain—intracranial aneurysm	0.000636	0.00132	CbGeAlD
Sunitinib—FYN—brain—intracranial aneurysm	0.000628	0.0013	CbGeAlD
Sunitinib—KDR—cerebellum—intracranial aneurysm	0.000617	0.00128	CbGeAlD
Sunitinib—MAP2K5—cerebellum—intracranial aneurysm	0.000617	0.00128	CbGeAlD
Sunitinib—MAP4K5—brain—intracranial aneurysm	0.000613	0.00128	CbGeAlD
Sunitinib—MAP3K3—brain—intracranial aneurysm	0.000613	0.00128	CbGeAlD
Sunitinib—CSF1R—cerebellum—intracranial aneurysm	0.000602	0.00125	CbGeAlD
Sunitinib—FLT1—brain—intracranial aneurysm	0.000593	0.00123	CbGeAlD
Sunitinib—EPHB6—brain—intracranial aneurysm	0.000586	0.00122	CbGeAlD
Sunitinib—YES1—brain—intracranial aneurysm	0.000566	0.00118	CbGeAlD
Sunitinib—STK10—brain—intracranial aneurysm	0.000561	0.00117	CbGeAlD
Sunitinib—TAOK3—brain—intracranial aneurysm	0.000559	0.00116	CbGeAlD
Sunitinib—PDGFRA—brain—intracranial aneurysm	0.000556	0.00116	CbGeAlD
Sunitinib—KIT—cerebellum—intracranial aneurysm	0.000547	0.00114	CbGeAlD
Sunitinib—PDGFRB—cerebellum—intracranial aneurysm	0.000534	0.00111	CbGeAlD
Sunitinib—KDR—brain—intracranial aneurysm	0.000501	0.00104	CbGeAlD
Sunitinib—MAP2K5—brain—intracranial aneurysm	0.000501	0.00104	CbGeAlD
Sunitinib—CSF1R—brain—intracranial aneurysm	0.000489	0.00102	CbGeAlD
Sunitinib—KCNH2—medulla oblongata—intracranial aneurysm	0.000477	0.000992	CbGeAlD
Sunitinib—KIT—brain—intracranial aneurysm	0.000444	0.000924	CbGeAlD
Sunitinib—KCNH2—midbrain—intracranial aneurysm	0.000436	0.000907	CbGeAlD
Sunitinib—PDGFRB—brain—intracranial aneurysm	0.000434	0.000902	CbGeAlD
Sunitinib—ABCG2—medulla oblongata—intracranial aneurysm	0.000425	0.000883	CbGeAlD
Sunitinib—ABCG2—midbrain—intracranial aneurysm	0.000388	0.000807	CbGeAlD
Sunitinib—ABCC4—brain—intracranial aneurysm	0.000345	0.000718	CbGeAlD
Sunitinib—KCNH2—cerebellum—intracranial aneurysm	0.000337	0.000702	CbGeAlD
Sunitinib—ABCG2—cerebellum—intracranial aneurysm	0.0003	0.000624	CbGeAlD
Sunitinib—KCNH2—brain—intracranial aneurysm	0.000274	0.00057	CbGeAlD
Sunitinib—ABCG2—brain—intracranial aneurysm	0.000244	0.000507	CbGeAlD
Sunitinib—ABCB1—medulla oblongata—intracranial aneurysm	0.000209	0.000435	CbGeAlD
Sunitinib—ABCB1—midbrain—intracranial aneurysm	0.000191	0.000398	CbGeAlD
Sunitinib—ABCB1—cerebellum—intracranial aneurysm	0.000148	0.000308	CbGeAlD
Sunitinib—ABCB1—brain—intracranial aneurysm	0.00012	0.00025	CbGeAlD
Sunitinib—JAK2—Immune System—CTSK—intracranial aneurysm	8.79e-05	0.000169	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—NCF1—intracranial aneurysm	8.77e-05	0.000169	CbGpPWpGaD
Sunitinib—JAK2—Axon guidance—MMP2—intracranial aneurysm	8.73e-05	0.000168	CbGpPWpGaD
Sunitinib—FGFR2—Disease—NCF1—intracranial aneurysm	8.71e-05	0.000168	CbGpPWpGaD
Sunitinib—TYK2—Axon guidance—MMP9—intracranial aneurysm	8.66e-05	0.000167	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—CCL2—intracranial aneurysm	8.66e-05	0.000167	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—CST3—intracranial aneurysm	8.6e-05	0.000166	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—AGER—intracranial aneurysm	8.58e-05	0.000165	CbGpPWpGaD
Sunitinib—KIT—Disease—NCF1—intracranial aneurysm	8.56e-05	0.000165	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—NCF1—intracranial aneurysm	8.55e-05	0.000165	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—AGER—intracranial aneurysm	8.49e-05	0.000163	CbGpPWpGaD
Sunitinib—STK11—Metabolism—NOS3—intracranial aneurysm	8.44e-05	0.000163	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—AGER—intracranial aneurysm	8.44e-05	0.000163	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—CST3—intracranial aneurysm	8.39e-05	0.000162	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—EDNRA—intracranial aneurysm	8.37e-05	0.000161	CbGpPWpGaD
Sunitinib—BLK—Immune System—AGER—intracranial aneurysm	8.37e-05	0.000161	CbGpPWpGaD
Sunitinib—FGR—Immune System—AGER—intracranial aneurysm	8.34e-05	0.000161	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—EDNRA—intracranial aneurysm	8.24e-05	0.000159	CbGpPWpGaD
Sunitinib—ROCK1—Developmental Biology—MMP9—intracranial aneurysm	8.24e-05	0.000159	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—NCF1—intracranial aneurysm	8.23e-05	0.000159	CbGpPWpGaD
Sunitinib—TYK2—Developmental Biology—MMP2—intracranial aneurysm	8.22e-05	0.000158	CbGpPWpGaD
Sunitinib—YES1—Hemostasis—NOS3—intracranial aneurysm	8.21e-05	0.000158	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—NCF1—intracranial aneurysm	8.18e-05	0.000158	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—NOS3—intracranial aneurysm	8.14e-05	0.000157	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—NOS3—intracranial aneurysm	8.14e-05	0.000157	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CTSB—intracranial aneurysm	8.14e-05	0.000157	CbGpPWpGaD
Sunitinib—FGFR1—Disease—NCF1—intracranial aneurysm	8.12e-05	0.000156	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—NCF1—intracranial aneurysm	8.1e-05	0.000156	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—NCF1—intracranial aneurysm	8.1e-05	0.000156	CbGpPWpGaD
Sunitinib—FYN—Disease—CST3—intracranial aneurysm	8.09e-05	0.000156	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—EDNRA—intracranial aneurysm	8.07e-05	0.000155	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—AGER—intracranial aneurysm	8.07e-05	0.000155	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—CST3—intracranial aneurysm	8.05e-05	0.000155	CbGpPWpGaD
Sunitinib—FGFR1—Axon guidance—MMP9—intracranial aneurysm	7.97e-05	0.000154	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CTSB—intracranial aneurysm	7.94e-05	0.000153	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—NCF1—intracranial aneurysm	7.93e-05	0.000153	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—NCF1—intracranial aneurysm	7.93e-05	0.000153	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—CCL2—intracranial aneurysm	7.92e-05	0.000153	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—NCF1—intracranial aneurysm	7.9e-05	0.000152	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—EDNRA—intracranial aneurysm	7.83e-05	0.000151	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—MMP9—intracranial aneurysm	7.8e-05	0.00015	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—EDNRA—intracranial aneurysm	7.77e-05	0.00015	CbGpPWpGaD
Sunitinib—KDR—Developmental Biology—MMP9—intracranial aneurysm	7.73e-05	0.000149	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—NCF1—intracranial aneurysm	7.73e-05	0.000149	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—EDNRA—intracranial aneurysm	7.72e-05	0.000149	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—NOS3—intracranial aneurysm	7.72e-05	0.000149	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—SLC25A16—intracranial aneurysm	7.71e-05	0.000148	CbGpPWpGaD
Sunitinib—JAK2—Disease—CST3—intracranial aneurysm	7.69e-05	0.000148	CbGpPWpGaD
Sunitinib—FYN—Immune System—CTSB—intracranial aneurysm	7.66e-05	0.000148	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—CCL2—intracranial aneurysm	7.62e-05	0.000147	CbGpPWpGaD
Sunitinib—FYN—Immune System—NCF1—intracranial aneurysm	7.62e-05	0.000147	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CTSB—intracranial aneurysm	7.62e-05	0.000147	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—NCF1—intracranial aneurysm	7.58e-05	0.000146	CbGpPWpGaD
Sunitinib—FGFR1—Developmental Biology—MMP2—intracranial aneurysm	7.57e-05	0.000146	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—EDNRA—intracranial aneurysm	7.49e-05	0.000144	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—EDNRA—intracranial aneurysm	7.49e-05	0.000144	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—EDNRA—intracranial aneurysm	7.48e-05	0.000144	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—NCF1—intracranial aneurysm	7.48e-05	0.000144	CbGpPWpGaD
Sunitinib—CSNK1A1—Disease—NOS3—intracranial aneurysm	7.35e-05	0.000142	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—CCL2—intracranial aneurysm	7.35e-05	0.000142	CbGpPWpGaD
Sunitinib—MAP2K2—Axon guidance—MMP9—intracranial aneurysm	7.34e-05	0.000141	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—EDNRA—intracranial aneurysm	7.3e-05	0.000141	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—NCF1—intracranial aneurysm	7.3e-05	0.000141	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CTSB—intracranial aneurysm	7.28e-05	0.00014	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—CCL2—intracranial aneurysm	7.24e-05	0.00014	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—CCL2—intracranial aneurysm	7.24e-05	0.00014	CbGpPWpGaD
Sunitinib—JAK2—Immune System—NCF1—intracranial aneurysm	7.24e-05	0.00014	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—NOS3—intracranial aneurysm	7.06e-05	0.000136	CbGpPWpGaD
Sunitinib—FYN—Disease—NCF1—intracranial aneurysm	7.03e-05	0.000136	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—CCL2—intracranial aneurysm	7.03e-05	0.000135	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—NCF1—intracranial aneurysm	7e-05	0.000135	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—MMP2—intracranial aneurysm	6.97e-05	0.000134	CbGpPWpGaD
Sunitinib—PRKAA2—Metabolism—NOS3—intracranial aneurysm	6.91e-05	0.000133	CbGpPWpGaD
Sunitinib—FYN—Axon guidance—MMP9—intracranial aneurysm	6.91e-05	0.000133	CbGpPWpGaD
Sunitinib—MAP2K1—Axon guidance—MMP9—intracranial aneurysm	6.87e-05	0.000132	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—NOS3—intracranial aneurysm	6.8e-05	0.000131	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ASAH1—intracranial aneurysm	6.77e-05	0.00013	CbGpPWpGaD
Sunitinib—YES1—Immune System—AGER—intracranial aneurysm	6.73e-05	0.00013	CbGpPWpGaD
Sunitinib—YES1—Developmental Biology—MMP9—intracranial aneurysm	6.71e-05	0.000129	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—NCF1—intracranial aneurysm	6.71e-05	0.000129	CbGpPWpGaD
Sunitinib—JAK2—Disease—NCF1—intracranial aneurysm	6.69e-05	0.000129	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—NOS3—intracranial aneurysm	6.63e-05	0.000128	CbGpPWpGaD
Sunitinib—JAK2—Axon guidance—MMP9—intracranial aneurysm	6.57e-05	0.000126	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—MMP2—intracranial aneurysm	6.56e-05	0.000126	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—MMP9—intracranial aneurysm	6.53e-05	0.000126	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—MMP9—intracranial aneurysm	6.53e-05	0.000126	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—MMP2—intracranial aneurysm	6.52e-05	0.000126	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—CCL2—intracranial aneurysm	6.48e-05	0.000125	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—CCL2—intracranial aneurysm	6.48e-05	0.000125	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—NOS3—intracranial aneurysm	6.46e-05	0.000124	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—NOS3—intracranial aneurysm	6.46e-05	0.000124	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—AGER—intracranial aneurysm	6.39e-05	0.000123	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—NCF1—intracranial aneurysm	6.36e-05	0.000123	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—EDNRA—intracranial aneurysm	6.34e-05	0.000122	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—NOS3—intracranial aneurysm	6.26e-05	0.000121	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—MMP2—intracranial aneurysm	6.23e-05	0.00012	CbGpPWpGaD
Sunitinib—TYK2—Immune System—AGER—intracranial aneurysm	6.2e-05	0.000119	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—MMP9—intracranial aneurysm	6.19e-05	0.000119	CbGpPWpGaD
Sunitinib—TYK2—Developmental Biology—MMP9—intracranial aneurysm	6.18e-05	0.000119	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—NCF1—intracranial aneurysm	6.18e-05	0.000119	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—CCL2—intracranial aneurysm	6.13e-05	0.000118	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—AGER—intracranial aneurysm	6.12e-05	0.000118	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—NCF1—intracranial aneurysm	6.1e-05	0.000118	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—CCL2—intracranial aneurysm	6.06e-05	0.000117	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—NOS3—intracranial aneurysm	6.03e-05	0.000116	CbGpPWpGaD
Sunitinib—KIT—Immune System—AGER—intracranial aneurysm	6.01e-05	0.000116	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—AGER—intracranial aneurysm	6.01e-05	0.000116	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—EDNRA—intracranial aneurysm	6.01e-05	0.000116	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—NCF1—intracranial aneurysm	5.99e-05	0.000115	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—NCF1—intracranial aneurysm	5.99e-05	0.000115	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—NOS3—intracranial aneurysm	5.94e-05	0.000114	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—EDNRA—intracranial aneurysm	5.83e-05	0.000112	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—NOS3—intracranial aneurysm	5.78e-05	0.000111	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—CCL2—intracranial aneurysm	5.78e-05	0.000111	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—EDNRA—intracranial aneurysm	5.76e-05	0.000111	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—NOS3—intracranial aneurysm	5.73e-05	0.00011	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—AGER—intracranial aneurysm	5.71e-05	0.00011	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—AGER—intracranial aneurysm	5.69e-05	0.00011	CbGpPWpGaD
Sunitinib—FGFR1—Developmental Biology—MMP9—intracranial aneurysm	5.69e-05	0.00011	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—NCF1—intracranial aneurysm	5.69e-05	0.00011	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—NCF1—intracranial aneurysm	5.67e-05	0.000109	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—MMP9—intracranial aneurysm	5.66e-05	0.000109	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—EDNRA—intracranial aneurysm	5.66e-05	0.000109	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—EDNRA—intracranial aneurysm	5.66e-05	0.000109	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—NOS3—intracranial aneurysm	5.46e-05	0.000105	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—MMP9—intracranial aneurysm	5.45e-05	0.000105	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—CCL2—intracranial aneurysm	5.45e-05	0.000105	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—CCL2—intracranial aneurysm	5.4e-05	0.000104	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—NOS3—intracranial aneurysm	5.4e-05	0.000104	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—EDNRA—intracranial aneurysm	5.37e-05	0.000103	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—EDNRA—intracranial aneurysm	5.36e-05	0.000103	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—AGER—intracranial aneurysm	5.26e-05	0.000101	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—MMP9—intracranial aneurysm	5.24e-05	0.000101	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NCF1—intracranial aneurysm	5.24e-05	0.000101	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—MMP9—intracranial aneurysm	5.18e-05	9.98e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—MMP9—intracranial aneurysm	5.18e-05	9.98e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—NOS3—intracranial aneurysm	5.15e-05	9.92e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—AGER—intracranial aneurysm	5.13e-05	9.88e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NCF1—intracranial aneurysm	5.11e-05	9.84e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ASAH1—intracranial aneurysm	5.11e-05	9.84e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—MMP9—intracranial aneurysm	5.02e-05	9.68e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EDNRA—intracranial aneurysm	4.95e-05	9.53e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—AGER—intracranial aneurysm	4.94e-05	9.52e-05	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—MMP9—intracranial aneurysm	4.93e-05	9.49e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NCF1—intracranial aneurysm	4.93e-05	9.49e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—AGER—intracranial aneurysm	4.92e-05	9.47e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—MMP9—intracranial aneurysm	4.9e-05	9.44e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NCF1—intracranial aneurysm	4.9e-05	9.44e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—CCL2—intracranial aneurysm	4.87e-05	9.38e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—NOS3—intracranial aneurysm	4.86e-05	9.35e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EDNRA—intracranial aneurysm	4.83e-05	9.3e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—NOS3—intracranial aneurysm	4.82e-05	9.28e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	4.75e-05	9.15e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—AGER—intracranial aneurysm	4.7e-05	9.05e-05	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—MMP9—intracranial aneurysm	4.68e-05	9.03e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NCF1—intracranial aneurysm	4.68e-05	9.02e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—CCL2—intracranial aneurysm	4.67e-05	8.99e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EDNRA—intracranial aneurysm	4.65e-05	8.96e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—MMP9—intracranial aneurysm	4.64e-05	8.93e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EDNRA—intracranial aneurysm	4.63e-05	8.91e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EDNRA—intracranial aneurysm	4.42e-05	8.52e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—MMP9—intracranial aneurysm	4.38e-05	8.44e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—CCL2—intracranial aneurysm	4.38e-05	8.44e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—CCL2—intracranial aneurysm	4.34e-05	8.36e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—MMP9—intracranial aneurysm	4.34e-05	8.35e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—NOS3—intracranial aneurysm	4.16e-05	8.02e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—MMP9—intracranial aneurysm	4.13e-05	7.96e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—CCL2—intracranial aneurysm	4.13e-05	7.95e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—CCL2—intracranial aneurysm	3.98e-05	7.66e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—NOS3—intracranial aneurysm	3.9e-05	7.52e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—MMP9—intracranial aneurysm	3.9e-05	7.5e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—NOS3—intracranial aneurysm	3.87e-05	7.45e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—MMP9—intracranial aneurysm	3.87e-05	7.45e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—CCL2—intracranial aneurysm	3.86e-05	7.43e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—CCL2—intracranial aneurysm	3.83e-05	7.38e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—CCL2—intracranial aneurysm	3.81e-05	7.33e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—CCL2—intracranial aneurysm	3.69e-05	7.11e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—CCL2—intracranial aneurysm	3.69e-05	7.11e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—CCL2—intracranial aneurysm	3.69e-05	7.11e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—NOS3—intracranial aneurysm	3.66e-05	7.05e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—NOS3—intracranial aneurysm	3.61e-05	6.96e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—CCL2—intracranial aneurysm	3.6e-05	6.93e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—NOS3—intracranial aneurysm	3.55e-05	6.84e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—NOS3—intracranial aneurysm	3.54e-05	6.83e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—NOS3—intracranial aneurysm	3.41e-05	6.58e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—NOS3—intracranial aneurysm	3.39e-05	6.53e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—NOS3—intracranial aneurysm	3.37e-05	6.49e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—NOS3—intracranial aneurysm	3.36e-05	6.47e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—MMP9—intracranial aneurysm	3.34e-05	6.43e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—NOS3—intracranial aneurysm	3.29e-05	6.34e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—NOS3—intracranial aneurysm	3.29e-05	6.34e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—NOS3—intracranial aneurysm	3.21e-05	6.17e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	3.15e-05	6.06e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—MMP9—intracranial aneurysm	3.13e-05	6.03e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—CCL2—intracranial aneurysm	3.12e-05	6.02e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—MMP9—intracranial aneurysm	3.1e-05	5.98e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—NOS3—intracranial aneurysm	3.1e-05	5.97e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—NOS3—intracranial aneurysm	3.03e-05	5.83e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—CCL2—intracranial aneurysm	2.96e-05	5.71e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—NOS3—intracranial aneurysm	2.92e-05	5.62e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—NOS3—intracranial aneurysm	2.9e-05	5.59e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CCL2—intracranial aneurysm	2.87e-05	5.54e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—MMP9—intracranial aneurysm	2.84e-05	5.48e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CCL2—intracranial aneurysm	2.84e-05	5.47e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CCL2—intracranial aneurysm	2.79e-05	5.37e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CCL2—intracranial aneurysm	2.79e-05	5.37e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—NOS3—intracranial aneurysm	2.78e-05	5.36e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—NOS3—intracranial aneurysm	2.77e-05	5.34e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—MMP9—intracranial aneurysm	2.74e-05	5.28e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—MMP9—intracranial aneurysm	2.72e-05	5.24e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CCL2—intracranial aneurysm	2.65e-05	5.1e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CCL2—intracranial aneurysm	2.64e-05	5.08e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—NOS3—intracranial aneurysm	2.64e-05	5.08e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—MMP9—intracranial aneurysm	2.64e-05	5.08e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—MMP9—intracranial aneurysm	2.64e-05	5.08e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—MMP9—intracranial aneurysm	2.57e-05	4.95e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—NOS3—intracranial aneurysm	2.56e-05	4.94e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—NOS3—intracranial aneurysm	2.53e-05	4.88e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—NOS3—intracranial aneurysm	2.49e-05	4.79e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—NOS3—intracranial aneurysm	2.49e-05	4.79e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CCL2—intracranial aneurysm	2.44e-05	4.69e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CCL2—intracranial aneurysm	2.38e-05	4.58e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—NOS3—intracranial aneurysm	2.36e-05	4.54e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—NOS3—intracranial aneurysm	2.35e-05	4.53e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CCL2—intracranial aneurysm	2.29e-05	4.42e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CCL2—intracranial aneurysm	2.28e-05	4.39e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MMP9—intracranial aneurysm	2.23e-05	4.3e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CCL2—intracranial aneurysm	2.18e-05	4.2e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NOS3—intracranial aneurysm	2.17e-05	4.18e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NOS3—intracranial aneurysm	2.12e-05	4.08e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MMP9—intracranial aneurysm	2.12e-05	4.08e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MMP9—intracranial aneurysm	2.06e-05	3.96e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NOS3—intracranial aneurysm	2.04e-05	3.94e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NOS3—intracranial aneurysm	2.03e-05	3.91e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MMP9—intracranial aneurysm	2.03e-05	3.91e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MMP9—intracranial aneurysm	1.99e-05	3.84e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MMP9—intracranial aneurysm	1.99e-05	3.84e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—NOS3—intracranial aneurysm	1.97e-05	3.8e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—NOS3—intracranial aneurysm	1.95e-05	3.76e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NOS3—intracranial aneurysm	1.94e-05	3.74e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MMP9—intracranial aneurysm	1.89e-05	3.65e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MMP9—intracranial aneurysm	1.89e-05	3.64e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MMP9—intracranial aneurysm	1.74e-05	3.36e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MMP9—intracranial aneurysm	1.7e-05	3.28e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MMP9—intracranial aneurysm	1.64e-05	3.16e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MMP9—intracranial aneurysm	1.63e-05	3.14e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MMP9—intracranial aneurysm	1.56e-05	3e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—NOS3—intracranial aneurysm	1.41e-05	2.72e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—NOS3—intracranial aneurysm	1.07e-05	2.05e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NOS3—intracranial aneurysm	6.56e-06	1.26e-05	CbGpPWpGaD
